We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Presepsin Concentrations Correlate with Kidney Function Decline

By LabMedica International staff writers
Posted on 24 Oct 2019
Sepsis is an important public health problem with more than 750,000 patients reported yearly in the USA with similar figures in Europe. More...
Sepsis continues to be a challenge for practitioners, as sepsis mortality rates are still high despite new antimicrobial and resuscitation agents.

Chronic kidney disease (CKD) is a worldwide health problem and its prevalence is rising, particularly in the elderly, mainly reflecting the increased life expectancy of the global population. The plasma presepsin concentrations of healthy individuals are very slight, but have been shown to increase in response to bacterial infections according to disease severity.

Medical scientists at the Nippon Medical School (Tokyo, Japan) and their colleagues enrolled CKD patients aged ≥65 years who had visited a nephrology outpatient department between April 2015 and March 2016. The median age of patients of this cohort was 77.8 (72-85) years and the mean estimated glomerular filtration rate (eGFR) was 51.8 ± 28.1 mL/min/1.73m2.

Serum creatinine was measured in serum specimens using an automated enzymatic method. Normal values of serum creatinine are <1.1 mg/dL for men and 0.7 mg/dL for women. Serum cystatin C was measured using a particle-enhanced immunonephelometric assay with the Siemens BN ProSpec nephelometer. C-reactive protein (CRP) was measured by latex-enhanced immunonephelometric assay with the Siemens BN ProSpec nephelometer.

Plasma presepsin concentrations were measured using an automated immunoassay analyzer based on noncompetitive chemiluminescent enzyme immunoassay. The relationship between plasma presepsin concentration and kidney function was assessed. eGFRcr, eGFRcys, CKD-EPI eGFRcr-cys were used to classify patients by GFR stage (G1-G5).

The scientists reported that plasma presepsin concentrations in those with CKD G4-G5 (362 pg/mL [273-553]) were significantly higher than in those with CKD G1-G2 (111 pg/mL [91-113]) and CKD G3 (145 pg/mL [124-205]). A high correlation between plasma presepsin concentrations and kidney function was observed. Even after adjusting for confounders, plasma presepsin concentrations were independently associated with kidney function.

The authors concluded that they had found that increases in plasma presepsin concentrations were exponentially correlated to decline in kidney function in the elderly with CKD. Prediction of plasma presepsin concentrations through commensurate decline in kidney function in the elderly should help in the precise diagnosis of sepsis in clinical practice. The study was published on October 5, 2019, in the journal Clinica Chimica Acta.

Related Links:
Nippon Medical School


New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.